Evoke Pharma Inc Annual Operating Lease, Payments in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Evoke Pharma Inc quarterly/annual Operating Lease, Payments history and growth rate from 2021 to 2023.
  • Evoke Pharma Inc Operating Lease, Payments for the quarter ending December 31, 2023 was $25.7K.
  • Evoke Pharma Inc Operating Lease, Payments for the twelve months ending December 31, 2023 was $146K, a 274% increase year-over-year.
  • Evoke Pharma Inc annual Operating Lease, Payments for 2023 was $146K, a 274% increase from 2022.
  • Evoke Pharma Inc annual Operating Lease, Payments for 2022 was $39K, a 71.5% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $146K +$107K +274% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
2022 $39K -$98K -71.5% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 $137K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.